Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Psoriatic rheumatism].

Thomas Bardin1

  • 1Fédération de rhumatologie, Centre Viggo-Petersen, hôpital Lariboisière, 75475 Paris Cedex 10. thomas.bardin@lrb.ap-hop-paris.fr

La Revue Du Praticien
|March 31, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening for transthyretin amyloid cardiomyopathy in patients with musculoskeletal symptoms: Red flags in the rheumatology/orthopedics practice setting.

Joint bone spine·2025
Same author

Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout.

Arthritis care & research·2025
Same author

Spermidine Reproduces the Anti-Inflammatory Effects of Intermittent Fasting and Prevents Urate and Calcium Pyrophosphate Crystal-Induced Inflammation.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Diagnostic pathway for cardiac amyloidosis from the healthcare professional's perspective: results from the French DIAM-ATTR survey.

Annals of medicine·2025
Same author

Time-course of tophus resolution on Dual-energy CT and ultrasound after 24months of a treat-to-target strategy: Results from GOUT-DECTUS study.

Joint bone spine·2025
Same author

Addition of allopurinol to traditional Vietnamese medicine shows major improvement of 100 gout patients in a single center one-year prospective study.

Joint bone spine·2025
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Psoriatic arthritis affects 5-7% of psoriasis patients, causing erosive inflammatory rheumatism primarily at entheses and joints. Treatments include NSAIDs, corticosteroids, and DMARDs like methotrexate for severe cases.

Area of Science:

  • Rheumatology
  • Dermatology
  • Immunology

Context:

  • Cutaneous psoriasis affects 5-7% of patients with inflammatory rheumatism.
  • This condition is seronegative for rheumatoid factor and often erosive.
  • Inflammation predominantly affects entheses and can impact axial or peripheral skeletons.

Purpose:

  • To describe the clinical presentation and management of psoriatic arthritis.
  • To highlight the common peripheral and axial skeletal involvements.
  • To outline treatment strategies for psoriatic arthritis.

Summary:

  • Psoriatic arthritis presents as asymmetrical oligo-arthritis or symmetrical polyarthritis, frequently affecting distal interphalangeal joints.
  • Axial involvement includes bilateral sacro-iliitis and ankylosing spondylitis-type spinal disease, predominantly in cervical and thoracic regions.

Related Experiment Videos

  • Severe mutilating forms are rare, but axial and peripheral joint inflammation requires careful management.

    • Impact:

    • Provides a comprehensive overview of psoriatic arthritis for clinicians and researchers.
    • Emphasizes the importance of early diagnosis and appropriate treatment to prevent joint damage.
    • Informs therapeutic decisions, including the judicious use of steroids and the role of DMARDs and TNFalpha inhibitors.